These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3613966

  • 21. [Liver damage of allergic origin during treatment with antitubercular agents].
    Kürti V, Novák O.
    Cas Lek Cesk; 1968 Jun 21; 107(26):780-4. PubMed ID: 5661073
    [No Abstract] [Full Text] [Related]

  • 22. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV.
    Probl Tuberk; 1968 Jun 21; 46(8):43-7. PubMed ID: 5709113
    [No Abstract] [Full Text] [Related]

  • 23. [Side reactions to antitubercular preparations and their prognosis in children and adolescents with tuberculosis].
    Piataeva Ev, Kazakov KS.
    Probl Tuberk; 1988 Jun 21; (3):67-9. PubMed ID: 3387399
    [No Abstract] [Full Text] [Related]

  • 24. [Ethambutol, capreomycin and rifampicin in lung tuberculosis].
    Hellström PE, Repo UK.
    Nord Med; 1968 Dec 19; 79(51):1723-9. PubMed ID: 5712754
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of intractable pulmonary tuberculosis].
    Azuma Y.
    Iryo; 1971 Nov 19; 25(11):827-32. PubMed ID: 5147771
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of intractable pulmonary tuberculosis].
    Kuze A.
    Iryo; 1971 Nov 19; 25(11):820-6. PubMed ID: 5147770
    [No Abstract] [Full Text] [Related]

  • 27. [Pulmonary tuberculosis in combination with syphilis].
    Andreeva LA, Gradusova MN.
    Probl Tuberk; 1983 Sep 19; (9):72-3. PubMed ID: 6647451
    [No Abstract] [Full Text] [Related]

  • 28. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P, Kokkola K.
    Scand J Respir Dis Suppl; 1972 Sep 19; 80():143-51. PubMed ID: 4510911
    [No Abstract] [Full Text] [Related]

  • 29. [Drug allergy in patients with pulmonary tuberculosis].
    Tabidze ShA.
    Probl Tuberk; 1986 Sep 19; (5):33-7. PubMed ID: 3737592
    [No Abstract] [Full Text] [Related]

  • 30. [Candidiasis as a complication of antibacterial therapy in pulmonary tuberculosis].
    Kovalenko LG.
    Probl Tuberk; 1965 Sep 19; 43(5):28-33. PubMed ID: 5858235
    [No Abstract] [Full Text] [Related]

  • 31. [Results of bronchoscopic examinations of tuberculosis patients undergoing complex chemotherapy].
    Abduraşitova TV.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Sep 19; 30(3):185-8. PubMed ID: 6273992
    [No Abstract] [Full Text] [Related]

  • 32. [Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
    German AK, Syrovatka IuA, Bondarenko VP.
    Vrach Delo; 1985 Oct 19; (10):98-100. PubMed ID: 4090447
    [No Abstract] [Full Text] [Related]

  • 33. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C, Bercion R, Koulla-Shiro S.
    East Afr Med J; 1997 Aug 19; 74(8):474-7. PubMed ID: 9487410
    [Abstract] [Full Text] [Related]

  • 34. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG, Maksimova NM.
    Probl Tuberk; 1984 Jan 19; (1):45-9. PubMed ID: 6422459
    [No Abstract] [Full Text] [Related]

  • 35. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV, Rudoĭ NM.
    Klin Med (Mosk); 1968 Dec 19; 46(12):36-43. PubMed ID: 5737381
    [No Abstract] [Full Text] [Related]

  • 36. [Pulmonary tuberculosis and liver damage].
    Vetter K, Kaschube I, Doepner G, Kettler LH.
    Dtsch Gesundheitsw; 1967 Apr 27; 22(17):783-7. PubMed ID: 5594492
    [No Abstract] [Full Text] [Related]

  • 37. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H.
    Prax Pneumol; 1973 Mar 27; 27(3):182-90. PubMed ID: 4699468
    [No Abstract] [Full Text] [Related]

  • 38. [Prognosis of the effectiveness of treatment of pulmonary tuberculosis].
    Bibik NF.
    Probl Tuberk; 1974 Mar 27; (12):22-6. PubMed ID: 4216897
    [No Abstract] [Full Text] [Related]

  • 39. [Inhalation therapy of tuberculosis patients with antitubercular agents of the first and second line].
    Kulik NM.
    Probl Tuberk; 1974 Mar 27; (8):34-7. PubMed ID: 4409857
    [No Abstract] [Full Text] [Related]

  • 40. Three-month retreatment in pulmonary tuberculosis.
    Chinachoti T, Jittinandana A.
    J Med Assoc Thai; 1983 May 27; 66(5):274-7. PubMed ID: 6875419
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.